Pulsed-field ablation for persistent atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests a new type of ablation (pulsed-field) to treat persistent atrial fibrillation (AFib) that lasts more than 7 days. You may qualify if you have symptoms and haven't had other heart ablation procedures except for one specific type.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have persistent atrial fibrillation (AFib) that has lasted longer than 7 days but less than 3 years
- You are not able to take, or do not want to take, antiarrhythmic drugs (medicines to control heart rhythm)
- You do not have a pacemaker or defibrillator, and have not had prior heart ablation (except for one specific type)
- Your heart's pumping strength (ejection fraction) is better than 15%
- You have no serious valve disease, congenital heart disease, or recent heart attack or surgery (within 6 months)
- You can read and understand study information and have signed a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer type of ablation (pulsed field ablation) for people with persistent atrial fibrillation who have already had one ablation. The goal is to see if it can fix the heart rhythm problem again.
This trial tests a catheter ablation procedure for people with persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days but less than a year). It aims to see if the procedure is safe and effective for restoring a normal heart rhythm.
This study tests a new way to treat persistent atrial fibrillation using short bursts of electricity (pulsed fields) to carefully reset the heart's rhythm. It may help people whose irregular heartbeat has not improved with medication.
This trial tests a new way to treat persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days) using a specialized mapping system. It aims to help people who have not gotten relief from medications or cannot tolerate them.
This trial tests a new type of ablation called PFA for people with persistent atrial fibrillation. It aims to see if targeting heart tissue changes can improve outcomes.
This trial compares a newer type of ablation (pulsed field) with the standard radiofrequency ablation for people with persistent atrial fibrillation that hasn't been treated with ablation before. The goal is to see which method works better and has fewer risks.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.